DiCE and ILCA Enter International Partnership Fighting Liver Cancer
Digestive Cancers Europe (DiCE) and the International Liver Cancer Association (ILCA) Start Official Partnership
DiCE and ILCA are both very pleased to report the signing of a Memorandum of Understanding between the two organisations . With DiCE’s focus on patients and the ILCA on liver cancer research and its related multidisciplinary experts, this begins a recognised and flourishing partnership that allows the two organisations to put their joint efforts behind finding new and novel ways to better the outcomes and quality of life of liver patients across Europe and now also the world. More than 800.000 people are diagnosed with this cancer each year throughout the world. Liver cancer is also a leading cause of cancer deaths worldwide, accounting for more than 700.000 people sadly passing away each year.
“Our organisations have the common goal of working to improve the situation for liver cancer patients and to provide support for both patients and carers throughout the patient treatment pathway, ” says Zorana Maravic, DiCE Chief Executive Officer, “This agreement allows us to be a stronger force for liver cancer patients globally in working towards these common goals.”
“Indeed ILCA is very much looking forward to our joint work in improving people’s lives – both patients and carers,” says Bruno Sangro ILCA Advocacy Leader and MD. “By joining the knowledge of our network of healthcare experts with the first-hand patient expertise and perspective that DiCE and its Members offer, we look forward to moving forward in new ways that can benefit the organisations and all liver cancer patients collectively.”
About the two organisations
The International Liver Cancer Association (ILCA) is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines. ILCA mission is to lead a global Community of physicians, scientists and allied professionals through education and research with the goal to better prevent and treat liver cancer. ILCA will do so by promoting novel pathogenic, diagnostic and therapeutic interventions for liver cancer by taking a transversal approach to research and bringing together scientists, physicians and allied professionals from all interrelated fields.
Digestive Cancers Europe (DiCE), represents the voice of patients with digestive cancers (oesophageal, gastric, colon, rectum, liver, pancreatic and rare cancers), their families and their careers. As the European umbrella organization, DiCE has a Membership of over 30 national associations and is still growing.
Would you like to know more about this? Please contact us.